共 59 条
[1]
Whitworth J.A., Mechanisms of glucocorticoid-induced hypertension, Kidney Int, 31, pp. 1213-1224, (1987)
[2]
Saruta T., Suzuki H., Handa M., Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome, J Clin Endocrinol Metab, 62, (1986)
[3]
Ulick S., Levine L.S., Rauh W., Et al., A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol, J Clin Endocrinol, 49, pp. 757-764, (1979)
[4]
Monder C., Shackleton C., Bradlow L., Et al., The syndrome of apparent mineralocorticoid excess: Its association with ll/?-dehydrogenase and 5/?-reductase deficiency and some consequences for corticosteroid metabolism, J Clin Endocrinol, 63, pp. 550-557, (1986)
[5]
Stewart P.M., Corrie J., Shackleton C., Syndrome of apparent mineralocorticoid excess: A defect in the cortisol cortisone shuttle, J Clin Invest, 82, (1988)
[6]
Edwards C., Stewart P.M., Burt D., Localization of ll?-hydroxysteroid dehydrogenase: Tissue-specific protector of the mineralocorticoid receptor, Lancet, 2, pp. 986-988, (1988)
[7]
Funder J.W., Pearce P.T., Smith R., Et al., Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated, Science, 242, pp. 583-585, (1989)
[8]
Kornel L., Wu F.-T., Saito Z., Essential hypertension: A derangement in corticosteroid metabolism? Rush-Presby- terian-St, Luke's Med Bull, 14, pp. 3-16, (1975)
[9]
Kornel L., Studies on the mechanism of mineralocorticoid hypertension: Evidence for the presence of in situ mechanism in the arterial wall for a direct action of mineralo- corticoids, Clin Biochem, 14, pp. 282-293, (1981)
[10]
Kornel L., Kanamarlapudi N., Travers T., Et al., Studies on high affinity binding of mineralo- and glucocorticoids in rabbit aorta cytosol, J Steroid Biochem, 16, pp. 245-264, (1982)